Comparable results in patients with acute lymphoblastic leukemia after related and unrelated stem cell transplantation.
Standard
Comparable results in patients with acute lymphoblastic leukemia after related and unrelated stem cell transplantation. / Dahlke, Joachim; Kröger, Nicolaus; Zabelina, Tatjana; Ayuketang Ayuk, Francis; Wolschke, Christine; Renges, Helmut-Hans; Krüger, William; Kruell, A; Hinke, A; Erttmann, Rudolf; Kabisch, Hartmut; Zander, Axel R.
in: BONE MARROW TRANSPL, Jahrgang 37, Nr. 2, 2, 2006, S. 155-163.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Comparable results in patients with acute lymphoblastic leukemia after related and unrelated stem cell transplantation.
AU - Dahlke, Joachim
AU - Kröger, Nicolaus
AU - Zabelina, Tatjana
AU - Ayuketang Ayuk, Francis
AU - Wolschke, Christine
AU - Renges, Helmut-Hans
AU - Krüger, William
AU - Kruell, A
AU - Hinke, A
AU - Erttmann, Rudolf
AU - Kabisch, Hartmut
AU - Zander, Axel R.
PY - 2006
Y1 - 2006
N2 - We report the results of 84 patients with ALL after related (n = 46) or unrelated (n = 38) allogeneic SCT. Mean recipient age was 23 years (range: 1-60) and median follow-up was 18 months (range: 1-133). Forty-three patients were transplanted in CR1; 25 in CR2 or CR3; four were primary refractory; four in PR; eight in relapse. The conditioning regimen consisted of TBI/VP16/CY (n = 76), TBI/VP16 (n = 2), TBI/CY (n = 2), Bu/VP16/CY (n = 4). The OS at 3 years was 45% (44% unrelated, 46% related). Univariate analysis showed a significantly better OS for patients
AB - We report the results of 84 patients with ALL after related (n = 46) or unrelated (n = 38) allogeneic SCT. Mean recipient age was 23 years (range: 1-60) and median follow-up was 18 months (range: 1-133). Forty-three patients were transplanted in CR1; 25 in CR2 or CR3; four were primary refractory; four in PR; eight in relapse. The conditioning regimen consisted of TBI/VP16/CY (n = 76), TBI/VP16 (n = 2), TBI/CY (n = 2), Bu/VP16/CY (n = 4). The OS at 3 years was 45% (44% unrelated, 46% related). Univariate analysis showed a significantly better OS for patients
M3 - SCORING: Zeitschriftenaufsatz
VL - 37
SP - 155
EP - 163
JO - BONE MARROW TRANSPL
JF - BONE MARROW TRANSPL
SN - 0268-3369
IS - 2
M1 - 2
ER -